Shots:
The US FDA has approved Tonmya (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults; commercially available in Q4’25
Approval was based on 2 P-III (RELIEF & RESILIENT) trial assessing Tonmya vs PBO in 503 & 457 pts, respectively in the US, where pts started on Tonmya 2.8mg & increased the dose…
